Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 245.00M | 282.00M | 220.00M | 222.00M | 226.00M |
| Total Depreciation and Amortization | 142.00M | 143.00M | 140.00M | 135.00M | 125.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 155.00M | 64.00M | 44.00M | 74.00M | 47.00M |
| Change in Net Operating Assets | 21.00M | 55.00M | -90.00M | 33.00M | -42.00M |
| Cash from Operations | 563.00M | 544.00M | 314.00M | 464.00M | 356.00M |
| Capital Expenditure | -144.00M | -108.00M | -117.00M | -123.00M | -106.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -34.00M | -17.00M | -- | -383.00M | -1.53B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.00M | 1.00M | 2.00M | 4.00M | 6.00M |
| Cash from Investing | -201.00M | -124.00M | -115.00M | -502.00M | -1.63B |
| Total Debt Issued | 10.00M | 185.00M | 215.00M | 0.00 | 1.85B |
| Total Debt Repaid | -10.00M | -401.00M | -600.00M | -1.00M | -1.00M |
| Issuance of Common Stock | 19.00M | 13.00M | 29.00M | 21.00M | 24.00M |
| Repurchase of Common Stock | -152.00M | 0.00 | -42.00M | -151.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -89.00M | -90.00M | -84.00M | -84.00M | -84.00M |
| Other Financing Activities | -25.00M | 0.00 | -79.00M | 45.00M | -14.00M |
| Cash from Financing | -247.00M | -293.00M | -561.00M | -170.00M | 1.77B |
| Foreign Exchange rate Adjustments | -2.00M | 4.00M | 1.00M | -7.00M | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.00M | 131.00M | -361.00M | -215.00M | 493.00M |